黃 立楷

Medicine & Life Sciences

1. Alzheimer Disease 69%
2. Amyloid 30%
3. Biomarkers 22%
4. Blood Vessels 19%
5. Caregivers 11%
6. Cholinesterase Inhibitors 36%
7. Clinical Trials 17%
8. Cognition 58%
9. Cognitive Dysfunction 100%
10. Cohort Studies 18%
11. Dementia 93%
12. Elderly 12%
13. Gait 12%
14. Gastrointestinal Microbiome 15%
15. Herpes Zoster Oticus 21%
16. Infarction 12%
17. International Classification of Diseases 11%
18. Japanese Encephalitis 19%
19. Japanese Encephalitis Virus 18%
20. Longitudinal Studies 25%
21. Lower Extremity 14%
22. Magnetic Resonance Imaging 12%
23. Medication Adherence 14%
24. Memory 11%
25. Mental Status and Dementia Tests 49%
26. Metabolic Networks and Pathways 13%
27. Myelitis 18%
28. Names 12%
29. Neurology 16%
30. Neurosciences 14%
31. Nursing Care 14%
32. Observational Studies 11%
33. Periodontitis 29%
34. Pharmacists 13%
35. Population 14%
36. Psychological Distress 13%
37. Rifaximin 20%
38. S-Adenosylmethionine 17%
39. Spinal Cord 11%
40. Stroke 55%
41. Sucrose 13%
42. Systemic Lupus Erythematosus 12%
43. Taiwan 39%
44. Therapeutics 13%
45. Transient Ischemic Attack 14%
46. University Hospitals 12%
47. Vertebral Artery 15%
48. Vitamin B 12 14%
49. Young Adult 13%